What is the recommended dosage of Evolocumab (Repatha)?

The recommended dosage of Evolocumab (Repatha) is indeed aligned with the choice indicating 420 mg every month. Evolocumab is a monoclonal antibody used to lower LDL cholesterol levels in patients with certain cardiovascular conditions.

The standard dosing regimen for Evolocumab can be administered as either a biweekly or monthly approach. While the biweekly option involves a 140 mg dose administered every two weeks, the monthly alternative allows for a single 420 mg injection, which can be particularly convenient for patients who prefer less frequent dosing. This option ensures effective management of cholesterol levels while optimizing adherence to the treatment plan.

The other dosing options do not match the official recommended guidelines for Evolocumab use. Understanding the correct dosing is essential for ensuring maximum therapeutic effectiveness and safety in managing conditions like hyperlipidemia.